Stryker, Beckman Coulter Former CEOs Offer Insight On Acquisition Strategies
This article was originally published in The Gray Sheet
Executive Summary
Maintaining sales relationships with existing customers after an acquisition is crucial to a successful integration, according to Stryker Chairman John Brown
You may also be interested in...
Stryker Emerges As Buyer Of Howmedica; $1.9 Bil. Price Includes Heavy Debt
Stryker's $1.9 bil. acquisition of Pfizer's Howmedica division will allow the firm to more quickly and efficiently penetrate the $10 bil. worldwide orthopedics market with new product introductions slated for release beginning in the year 2000, the company says.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.